Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00214916
Status:
UNKNOWN
Last Update Posted:
2022-03-10
First Post:
2005-09-19
Brief Title:
Tight Glycemic Control With Intensive Insulin Therapy in PICU
Sponsor:
Greet Van den Berghe
Organization:
KU Leuven
Study Overview
Official Title:
KULeuven Intensive Insulin Study in Pediatric Intensive Care Patients
Status:
UNKNOWN
Status Verified Date:
2022-03
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In a previous study the investigators showed that tight blood glucose control with insulin during intensive care reduced morbidity and mortality in adult intensive care patients Whether this intervention also improves prognosis of pediatric intensive care patients remains unknown The current prospective randomized controlled study will asses the impact of intensive insulin therapy on outcome of patients in a pediatric intensive care unit On admission patients will be randomly assigned to either strict normalization of blood glucose according age adjusted values or the conventional approach in which insulin infusion is initiated only when blood glucose exceeds 215 mgdl to maintain blood glucose levels between 180-200 mgdl
Detailed Description:
Study type Interventional study
Study design single centre prospective randomized active control parallel assignment efficacy study
Study design single centre prospective randomized active control parallel assignment efficacy study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCT00214916 | None | None | None |